Swiss Group for Clinical Cancer Research: Breast Neoplasms trials

The registry lists 15 Breast Neoplasms studies with Swiss Group for Clinical Cancer Research as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 9Phase 3 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Activity Program During Aromatase Inhibitor TherapyCompletedNCT03786198Not applicable
• Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast CancerTerminatedNCT02833766Phase 2
• Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast CancerTerminatedNCT02404506Phase 2
• Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast CancerCompletedNCT02311543Phase 3
• CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerTerminatedNCT02067741Phase 2
• Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast CancerCompletedNCT01926964
• Trastuzumab & Pertuzumab Followed by T-DM1 in MBCCompletedNCT01835236Phase 2
• Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor TherapyCompletedNCT01160718Phase 2
• Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
• F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast CancerCompletedNCT00992706Phase 3
• Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00445406Phase 2
• Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast CancerCompletedNCT00238290Phase 2
• Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00031876Phase 1/2
• Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2TerminatedNCT00004935Phase 3
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementCompletedNCT00003902Phase 1/2